Autism Spectrum Disorder

The supplied grounding supports a genetic contribution, including associations from genome-wide studies and single-nucleotide polymorphism analyses. It also supports investigation of microbiome-related and brain-gut axis factors, but does not establish a single cause.

The literature grounding points to altered neuronal plasticity, signal transduction, transcriptome and gene regulatory network changes, and involvement of proteins such as trkB, cytokines, tumor necrosis factor-alpha, interleukin-4, and membrane proteins. It also supports a role for gut microbiota and microbiota-derived metabolites in bidirectional brain-gut communication, with immunological, neuronal, and endocrine pathways implicated.

The supplied grounding supports biological sex, sociodemographic status, ethnicity/race, and nativity as factors examined in relation to prevalence variation, but not as established causal risk factors. It also includes genetic variation and microbiome-related factors as areas of study, without defining them as confirmed risks.

The grounding supports therapy and drug therapy as literature topics, but it does not provide specific treatment standards or modalities for autism spectrum disorder. No supported standard-of-care treatment category can be stated from the supplied material alone.